Wednesday, May 1, 2024
ADVT 
Health

Health panel proposes colon cancer tests start at 45, not 50

Darpan News Desk The Canadian Press, 27 Oct, 2020 06:43 PM
  • Health panel proposes colon cancer tests start at 45, not 50

A panel of health experts wants U.S. adults to start getting colon cancer screenings at age 45, five years younger than it previously recommended.

While overall, colon cancer rates have been declining, the draft guidelines issued Tuesday by the U.S. Preventive Services Task Force reflect a growing concern about rising rates in people under the age of 50.

“We’ve seen more data showing that younger people are getting colon cancer at higher rates," said Dr. Alex Krist, a family doctor at Virginia Commonwealth University and a member of the task force. "Basically a 45-year-old today has the same risk of getting colon cancer as a 50-year-old from years past.”

The task force is a volunteer panel of doctors that regularly reviews evidence and issues advice on medical tests and treatments.

The group is proposing that adults of average risk for colon cancer be screened from ages 45 to 75. How often the tests are done depends on the type of screening: a colonoscopy is usually every five to 10 years while stool-based tests are every year.

“Most people who get colon cancer have no signs, no symptoms and no risks. And so that’s why we recommend that everyone get screened,” Krist said.

More frequent testing is recommended for those with abnormal colon polyps or a family history of colon cancer or genetic disorders that increase their risk for the disease. Tuesday's proposal also emphasizes that the disease occurs more often, is screened for less and leads to more deaths in Black adults.

Colon cancer, along with rectal cancer, is the third leading cause of cancer deaths in the U.S., with an estimated 148,000 new cases this year.

The task force proposal brings it in line with guidelines from the American Cancer Society, which in 2018 lowered the screening age from 50 to 45. With the change, doctors should feel comfortable recommending colon cancer screens to younger patients, said the cancer group's Robert Smith.

“We’ve been anticipating this for a while,” Smith said.

Earlier testing would help detect precancerous polyps or early cancer in younger patients before the disease requires more aggressive treatment, said Dr. Nancy You of MD Anderson Cancer Center in Houston.

“We have a lot more treatment options that are less invasive and have better results when we treat cancer at the earlier stages," she said. "That makes a huge difference to our patients.”

Experts anticipate it will still be a challenge getting people screened. Currently, 1 in 4 people between 50 and 75 have never been screened for the disease, and only about 60% of U.S. adults are up to date on their colon cancer screenings, Krist said.

If the recommendations are finalized, screenings for younger people would be covered by most private insurance plans, with no copay. The Affordable Care Act mandates that insurers cover services recommended by the task force.

The proposal is open for public comment through Nov. 23.

MORE Health ARTICLES

Pandemic pushes expansion of 'hospital-at-home' treatment

Pandemic pushes expansion of 'hospital-at-home' treatment
As hospitals care for people with COVID-19 and try to keep others from catching the virus, more patients are opting to be treated where they feel safest: at home.

Pandemic pushes expansion of 'hospital-at-home' treatment

Pharmacists can give childhood shots, U.S. officials say

Pharmacists can give childhood shots, U.S. officials say
Pharmacists in all 50 states are now allowed to give childhood vaccinations under a new directive aimed at preventing future outbreaks of measles and other preventable diseases.

Pharmacists can give childhood shots, U.S. officials say

Trail of bubbles leads scientists to new coronavirus clue

Trail of bubbles leads scientists to new coronavirus clue
A doctor checking comatose COVID-19 patients for signs of a stroke instead stumbled onto a new clue about how the virus may harm the lungs -- thanks to a test that used tiny air bubbles and a robot.

Trail of bubbles leads scientists to new coronavirus clue

FDA blocks much-anticipated BioMarin hemophilia gene therapy

FDA blocks much-anticipated BioMarin hemophilia gene therapy
Investors fled drug developer BioMarin in droves on Wednesday, driving shares down by a third after U.S. regulators rejected the company’s potentially game-changing hemophilia A gene therapy over concerns it might not really be a one-and-done lifetime treatment.

FDA blocks much-anticipated BioMarin hemophilia gene therapy

Many steps needed for accurate COVID-19 test results

Many steps needed for accurate COVID-19 test results
A widely used coronavirus test is under scrutiny this week after federal health officials warned that it could deliver inaccurate results if laboratory technicians don't follow the the latest updates from the manufacturer.

Many steps needed for accurate COVID-19 test results

Has the coronavirus mutated in any significant way?

Has the coronavirus mutated in any significant way?
Has the coronavirus mutated in any significant way?

Has the coronavirus mutated in any significant way?